- Public Health England
- Part of:
- Immunisation patient group direction (PGD) templates
- 6 November 2015
- Last updated:
- 19 October 2017, see all updates
PGD template to support the national diphtheria, tetanus and inactivated poliomyelitis (Td/IPV - Revaxis®) vaccination programme.
Diphtheria, tetanus and inactivated poliomyelitis vaccine (Td/IPV - Revaxis®): patient group direction (PGD) template
Ref: PHE publications gateway number: 2015425 MS Word Document, 142KB
This file may not be suitable for users of assistive technology. Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email email@example.com. Please tell us what format you need. It will help us if you say what assistive technology you use.
This patient group direction (PGD) template is to support the administration of diphtheria, tetanus and inactivated poliomyelitis vaccine (Td/IPV), to individuals from 10 years of age, in accordance with national recommendations and the routine childhood immunisation programme.
It is valid from 1 November 2017 to 31 October 2019.
Practitioners must not use this PGD template until it has been authorised in Section 2. This is a legal requirement (see Human Medicines Regulations 2012). Practitioners should follow local policy/procedures to access authorised PGD documents.
Published: 6 November 2015
Updated: 19 October 2017
- Reviewed and updated to add management of cases and contacts.
- First published.